Megan Coder (@meganecoder) 's Twitter Profile
Megan Coder

@meganecoder

Executive Director, Digital Therapeutics Alliance

ID: 2810232019

linkhttp://www.dtxalliance.org calendar_today14-09-2014 22:02:27

156 Tweet

870 Takipçi

774 Takip Edilen

Megan Coder (@meganecoder) 's Twitter Profile Photo

DTA is launching a search for another key leader to join our team. I look forward to working with this individual and DTA members long-term to further expand our work globally!

Megan Coder (@meganecoder) 's Twitter Profile Photo

Two reasons to celebrate - not only will I be continuing my work with DTA from the Isle of Jersey - but we also have Andy coming on board to accelerate many of our ongoing and new efforts!

Jessica DaMassa (@jessdamassa) 's Twitter Profile Photo

The ULTIMATE state-of-play on #digitaltherapeutics led by Megan Coder of @dtx_alliance. The overarching question: Where does the process for scaling #DTx converge with traditional Rx scaling? How closely will DTx co’s follow big pharma’s Playbook?

The ULTIMATE state-of-play on #digitaltherapeutics led by <a href="/meganecoder/">Megan Coder</a> of @dtx_alliance. 

The overarching question: 

Where does the process for scaling #DTx converge with traditional Rx  scaling? How closely will DTx co’s follow big pharma’s Playbook?
Megan Coder (@meganecoder) 's Twitter Profile Photo

It’s absolutely wonderful being back in person and diving into how we are moving far beyond the basics of digital therapeutics @dtx_alliance #FH21

Megan Coder (@meganecoder) 's Twitter Profile Photo

For those looking to take a deeper dive into what digital therapeutics are, the value they bring to patient care, and how these products are developed, studied, regulated, and supported - this would be a good place to start

Sleepio (@sleepio) 's Twitter Profile Photo

(UK) Sleepio has become the 1st #DTx to receive positive guidance from NICE & is found to be cost-saving for the NHS & more clinically effective than treatment as usual. We hope this acts as a catalyst for NHS England to provide access to Sleepio. nice.org.uk/news/article/n…

Megan Coder (@meganecoder) 's Twitter Profile Photo

Second time in three days where a national discussion features the use of a DTx - this time virtual reality - as a first-line therapy over drugs AppliedVR @BehaVR_al

RealizedCare (@realizedcare) 's Twitter Profile Photo

Spot on Megan Coder “If decision-makers in every city, state, region, and nation are creating their own requirements... ...then a digital therapeutic manufacturer has a very low likelihood of being able to meet all of those requirements for all those different entities”

Megan Coder (@meganecoder) 's Twitter Profile Photo

This was a wonderful panel to moderate as a kickoff to #HIMSS22Europe. Steven Gilbert OBE made a point I'll be thinking about for a while: "Available to everyone doesn't mean it is accessible to everyone."

Megan Coder (@meganecoder) 's Twitter Profile Photo

“Ethical frameworks need to be just as important as the technical advances that continue to emerge.” -Australian British Health Catalyst 2022

“Ethical frameworks need to be just as important as the technical advances that continue to emerge.” -Australian British Health Catalyst 2022
karine soulat (@kasulat) 's Twitter Profile Photo

Aujourd'hui enfin une explication simple pour savoir où une #DTX peut agir. Dans le diagnostic, le monitoring... #DTxFrance Megan Coder @EmilieLopesFer1

Aujourd'hui enfin une explication simple pour savoir où une #DTX peut agir. Dans le diagnostic, le monitoring... #DTxFrance <a href="/meganecoder/">Megan Coder</a> @EmilieLopesFer1
Jessica DaMassa (@jessdamassa) 's Twitter Profile Photo

Crazy how fast the conversation about #digitaltherapeutics has evolved. Hot now Frontiers Health: sufficiency of clinical trials and scaling up adoption. POWERHOUSE speakers: Megan Coder Hannes Klöpper Jeff Dachis kristinmilburn Sai Shankar, Sam Oddson, Jacine Hadijat #FH22

Crazy how fast the conversation about #digitaltherapeutics has evolved. Hot now <a href="/FrontiersHealth/">Frontiers Health</a>: sufficiency of clinical trials and scaling up adoption. POWERHOUSE speakers: <a href="/meganecoder/">Megan Coder</a> <a href="/HannesKlopper/">Hannes Klöpper</a> <a href="/jeffdachis/">Jeff Dachis</a> <a href="/kristinmilburn/">kristinmilburn</a> Sai Shankar, Sam Oddson, Jacine Hadijat #FH22
Frontiers Health (@frontiershealth) 's Twitter Profile Photo

This last panel for our DAY 1 of #FH22 is moderated by Megan Coder and explores the possibility to scale digital therapeutics solutions and inform new evolving pathways policymakers can leverage to create and redefine Dtx market access

This last panel for our DAY 1 of #FH22 is moderated by 
<a href="/meganecoder/">Megan Coder</a> and explores the possibility to scale digital therapeutics solutions and inform new evolving pathways policymakers can leverage to create and redefine Dtx market access
Digital Health Today (@dhealthtoday) 's Twitter Profile Photo

Don't miss out on the opportunity of the year at DTx Asia to meet the leaders in Asian Digital Medicine, as they bring together DTx, Pharma, Government Officials, Provider Groups and more! Register now: dtxasia.com/register/

Don't miss out on the opportunity of the year at DTx Asia to meet the leaders in Asian Digital Medicine, as they bring together DTx, Pharma, Government Officials, Provider Groups and more!

Register now: dtxasia.com/register/